James L. Mohler

25.9k total citations · 4 hit papers
395 papers, 14.6k citations indexed

About

James L. Mohler is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, James L. Mohler has authored 395 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Pulmonary and Respiratory Medicine, 95 papers in Molecular Biology and 64 papers in Surgery. Recurrent topics in James L. Mohler's work include Prostate Cancer Treatment and Research (172 papers), Prostate Cancer Diagnosis and Treatment (109 papers) and Hormonal and reproductive studies (43 papers). James L. Mohler is often cited by papers focused on Prostate Cancer Treatment and Research (172 papers), Prostate Cancer Diagnosis and Treatment (109 papers) and Hormonal and reproductive studies (43 papers). James L. Mohler collaborates with scholars based in United States, Canada and Germany. James L. Mohler's co-authors include Christopher W. Gregory, Frank S. French, O. Harris Ford, Jack A. Taylor, Douglas A. Bell, Mark Titus, Desok Kim, Alan W. Partin, Emily Wilson and Cary N. Robertson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

James L. Mohler

377 papers receiving 14.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder Cancer

1993 599 citations James L. Mohler et al. profile →
The Androgen Axis in Recurrent Prostate Cancer

2004 537 citations James L. Mohler, Christopher W. Gregory et al. Clinical Cancer Research profile →
Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment

2023 440 citations James L. Mohler et al. profile →
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection

2018 226 citations James L. Mohler et al. profile →

Peers

Countries citing papers authored by James L. Mohler

Since Specialization

Citations

This map shows the geographic impact of James L. Mohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Mohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Mohler more than expected).

Fields of papers citing papers by James L. Mohler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Mohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Mohler. The network helps show where James L. Mohler may publish in the future.

Co-authorship network of co-authors of James L. Mohler

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Mohler. A scholar is included among the top collaborators of James L. Mohler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Mohler. James L. Mohler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trusted Information Sources About the COVID-19 Vaccine Vary in Underserved Communities 2024 ·Journal of Community Health ·(unknown), (unknown), (unknown), (unknown), (unknown), Matthew Cole, (unknown), Jihnhee Yu, Gene D. Morse, James L. Mohler, Rolanda L. Ward	2
2	Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance 2024 ·The Prostate ·Renjie Jin, Connor M. Forbes, Nicole L. Miller, John T. Lafin, Douglas W. Strand, Thomas C. Case, Justin Cates, Qi Liu, Marisol Ramirez‐Solano, James L. Mohler, Robert J. Matusik	5
3	Classification of subtask types and skill levels in robot-assisted surgery using EEG, eye-tracking, and machine learning 2024 ·Surgical Endoscopy ·Somayeh B. Shafiei, (unknown), James L. Mohler, Eric Kauffman, Matthew Holden, (unknown)	2
4	Surgical skill level classification model development using EEG and eye-gaze data and machine learning algorithms 2023 ·Journal of Robotic Surgery ·Somayeh B. Shafiei, (unknown), James L. Mohler, Farzan Sasangohar, (unknown), Mehdi Seilanian Toussi, (unknown)	10
5	Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients 2022 ·The Prostate ·Renjie Jin, Connor M. Forbes, Nicole L. Miller, Douglas W. Strand, Thomas C. Case, Justin Cates, Hye‐Young Kim, Phillip A. Wages, Ned A. Porter, (unknown), (unknown), James L. Mohler, Robert J. Matusik	9
6	Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity 2021 ·Clinical Cancer Research ·Yanping Wang, Sungyong You, Shengchen Su, Austin Yeon, (unknown), Sungjin Kim, James L. Mohler, Michael R. Freeman, Hyung L. Kim	26
7	A Direct Synthesis of 2‐(ω‐Carboxyalkyl)isoflavones from ortho‐Hydroxylated Deoxybenzoins 2018 ·European Journal of Organic Chemistry ·(unknown), (unknown), S. P. Bondarenko, Vitaliy M. Sviripa, (unknown), James L. Mohler, Michael V. Fiandalo, Chunming Liu, M. S. Frasinyuk, David S. Watt	2
8	Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Emma H. Allott, Laura Farnan, Susan E. Steck, Lenore Arab, L. Joseph Su, Merle H. Mishel, Elizabeth T. H. Fontham, James L. Mohler, Jeannette T. Bensen	17
9	Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action 2016 ·Database ·Adam DePriest, Michael V. Fiandalo, Simon Schlanger, (unknown), James L. Mohler, Song Liu, Hannelore V. Heemers	23
10	Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project 2016 ·Prostate Cancer and Prostatic Diseases ·Emma H. Allott, Lenore Arab, L. Joseph Su, Laura Farnan, Elizabeth T. H. Fontham, James L. Mohler, Jeannette T. Bensen, Susan E. Steck	30
11	Sequential Use of the Androgen Synthesis Inhibitors Ketoconazole and Abiraterone Acetate in Castration-Resistant Prostate Cancer and the Predictive Value of Circulating Androgens 2014 ·Clinical Cancer Research ·Won Kim, Li Zhang, John H. Wilton, Gerald J. Fetterly, James L. Mohler, Vivian Weinberg, (unknown), Russell Z. Szmulewitz, Terence W. Friedlander, Lawrence Fong, Amy Lin, Andrea Harzstark, Arturo Molina, Eric J. Small, Charles J. Ryan	31
12	A Randomized Pilot Trial of Dietary Modification for the Chemoprevention of Noninvasive Bladder Cancer: The Dietary Intervention in Bladder Cancer Study 2013 ·Cancer Prevention Research ·J. Kellogg Parsons, John P. Pierce, Loki Natarajan, Vicky A. Newman, (unknown), James L. Mohler, Cheryl L. Rock, Dennis D. Heath, Khurshid A. Guru, Michael B. Jameson, Hongying Li, Hossein Mirheydar, Michael Holmes, James R. Marshall	13
13	Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells 2012 ·Clinical Cancer Research ·Shahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, Kristopher Attwood, (unknown), (unknown), Charles Manhardt, (unknown), Stacey S. Willard, Hillary Thompson, (unknown), Katayoon Rezaei, Oliver Sartor, James L. Mohler, Robert L. Vessella	115
14	14-3-3η Amplifies Androgen Receptor Actions in Prostate Cancer 2009 ·Clinical Cancer Research ·Mark Titus, Jiann-an Tan, Christopher W. Gregory, O. Harris Ford, Romesh R. Subramanian, Haian Fu, Elizabeth M. Wilson, James L. Mohler, Frank S. French	13
15	Phenotype-Specific CpG Island Methylation Events in a Murine Model of Prostate Cancer 2008 ·Cancer Research ·Marta Camoriano, Shannon R. Morey Kinney, Michael T. Moser, Barbara A. Foster, James L. Mohler, Donald L. Trump, Adam R. Karpf, Dominic J. Smiraglia	15
16	Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer 2005 ·Clinical Cancer Research ·Mark Titus, Michael J. Schell, Fred B. Lih, Kenneth B. Tomer, James L. Mohler	398
17	Activated Tyrosine Kinase Ack1 Promotes Prostate Tumorigenesis: Role of Ack1 in Polyubiquitination of Tumor Suppressor Wwox 2005 ·Cancer Research ·Nupam P. Mahajan, Young E. Whang, James L. Mohler, H. Shelton Earp	176
18	Flash 5.0: Graphics, Animation and Interactivity 2001 ·James L. Mohler	3
19	Androgen Receptor Up-Regulates Insulin-Like Growth Factor Binding Protein-5 (IGFBP-5) Expression in a Human Prostate Cancer Xenograft* 1999 ·Endocrinology ·Christopher W. Gregory, Desok Kim, Ping Ye, A. Joseph D’Ercole, Thomas G. Pretlow, James L. Mohler, Frank S. French	56
20	Improving the Delivery of Instructional Graphics on the Web with Vector Technology 1999 ·James L. Mohler	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact